<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJIM</journal-id><journal-title-group><journal-title>Open Journal of Internal Medicine</journal-title></journal-title-group><issn pub-type="epub">2162-5972</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojim.2019.91001</article-id><article-id pub-id-type="publisher-id">OJIM-90483</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Deep Vein Thrombosis in HIV and Tuberculosis Treatment in a Case of a 19-Year-Old Guinean Student
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Djibril</surname><given-names>Sylla</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Amadou</surname><given-names>Kake</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Abdoulaye</surname><given-names>Camara</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ibrahima</surname><given-names>Sory Barry</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ibrahima</surname><given-names>Camara</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Boh</surname><given-names>Fanta Diane</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Fodé</surname><given-names>Amara Traore</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mariame</surname><given-names>Beavogui</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mamadou</surname><given-names>Dadhi Balde</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Medico-Surgical Emergency Department of Donka National Hospital, Conakry, Guinea</addr-line></aff><aff id="aff4"><addr-line>Dermatology Department of Donka National Hospital, Conakry, Guinea</addr-line></aff><aff id="aff3"><addr-line>Cardiac Service of Ignace Deen National Hospital, Conakry, Guinea</addr-line></aff><aff id="aff2"><addr-line>Department of Diabetes and Metabolic Diseases at Donka National Hospital, Conakry, Guinea</addr-line></aff><aff id="aff5"><addr-line>Department of Infectious and Tropical Diseases at Donka National Hospital, Conakry, Guinea</addr-line></aff><pub-date pub-type="epub"><day>13</day><month>02</month><year>2019</year></pub-date><volume>09</volume><issue>01</issue><fpage>1</fpage><lpage>4</lpage><history><date date-type="received"><day>12,</day>	<month>December</month>	<year>2018</year></date><date date-type="rev-recd"><day>10,</day>	<month>February</month>	<year>2019</year>	</date><date date-type="accepted"><day>13,</day>	<month>February</month>	<year>2019</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  The objective of this study was to describe Thrombotic manifestations and therapeutic management during HIV infection and tuberculosis in a 19-year-old male student. The objective of this study was to describe Thrombotic manifestations and therapeutic management during HIV infection and tuberculosis in a 19-year-old student. 
  <b>Observation:</b> It is Mr. S. C., aged 19, admitted for pain and swelling of the right lower limb, physical asthenia and notion of fever. Evolution 5 days, with no particular history of cardiovascular disease, anti-retroviral treatment for 1 year and anti-tuberculosis treatment for 3 months. On clinical examination heart sounds are irregular with a heart rate at 115 bpm, blood pressure at 110/70 mmhg. A febrile red painful swelling at right lower limb with positive Homans sign. 0&#176;C (Temperature 37.7&#176;C), Weight at 58 Kg. The rest of the clinical examination is without particularity. Venous Doppler echo of the lower limbs: shows the presence of acute deep vein thrombosis of the right lateral vein. Mr. S. C. to benefit the following Medical Treatment: lovenox 0.6 UI subcutaneously morning and evening, Sintrom 4 mg 1 comprimed at night, Tramadol 50 mg morning and evening; with a good clinical evolution. CONCLUSION: TB and HIV are chronic infections that result in widespread inflammation predisposing patients to a MTVE (Venous thromboembolic disease) table as well as rifampicin and anti-proteases.
 
</p></abstract><kwd-group><kwd>TB</kwd><kwd> HIV</kwd><kwd> Thrombosis</kwd><kwd> Young Person</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>The objective of this study was to describe thrombotic manifestations and therapeutic management during HIV infection and tuberculosis in a 19-year-old male student.</p><p>Some authors have estimated that the true prevalence of VTE may be greater than 10% but it is unknown in two thirds of cases [<xref ref-type="bibr" rid="scirp.90483-ref1">1</xref>] . Tuberculosis is considered a risk factor for thromboembolic venous diseases (VTE). The prevalence of this association varies between 0.6% and 10% [<xref ref-type="bibr" rid="scirp.90483-ref2">2</xref>] . Thromboembolic disease is increasingly reported during infection with the human immunodeficiency virus (HIV). It interests the venous territory with predilection [<xref ref-type="bibr" rid="scirp.90483-ref3">3</xref>] .</p></sec><sec id="s2"><title>2. Observation</title><p>This is Mr. S. C, aged 19, admitted for pain and swelling of the lower right limb, physical asthenia and fever concept. Evolution 5 days, no particular history of cardiovascular disease, anti-retroviral treatment for 1 year and anti-tuberculosis treatment for 3 months. On clinical examination the heart sounds are irregular with a heart rate at 115 bpm, blood pressure at 110/70 mmhg. There is a febrile red painful swelling at the right lower limb with positive Homans sign. Temperature 37.7˚C, Weight at 58 Kg. The rest of the clinical examination is without particularity.</p><p>Mr. S. C. to benefit the following medical treatment: lovenox 0.6 UI subcutaneously morning and evening, Sintrom 4 mg 1 comprimed in the evening, Tramadol 50 mg morning and evening; with good clinical outcome RESULTS: Tuberculosis and HIV infection are chronic infections that result in widespread inflammation predisposing patients to MTVE, rifampicin, and protease inhibitors.</p><p>Electrocardiogram: normal appearance.</p><p>Facial telethorax: rounded pulmonary opacities localized in the right upper lobe.</p><p>Venous Doppler echo of the lower limbs: shows the presence of acute deep vein thrombosis of the right lateral vein.</p><p>Biology: THB at 9 g/l, VS at H1 = 91 mm, VS at H2 = 102 mm, CRP = 60 mg/l, TP = 28%, 1st INR: 2.41, 2nd INR: 3, Coagulation time = 26''4 s, VIH positive Serologie, D-dimer &#224; 800 mg/ml, platelet count: 242 G/l.</p><p>Diagnostic: In all, the diagnosis of deep vein thrombosis was retained in the field of HIV and tuberculosis.</p></sec><sec id="s3"><title>3. Discussion</title><p>We report the case of a 19-year-old student with deep venous thrombosis of the lower right limb under anti-tuberculous and anti-retroviral treatment.</p><p>As early as 1856, R. Virchow described in his triad the mechanisms that can contribute to the formation of a thrombus: the alteration of coagulation, the lesion of the vascular wall and the venous stasis, these 3 mechanisms being often entangled [<xref ref-type="bibr" rid="scirp.90483-ref4">4</xref>] - [<xref ref-type="bibr" rid="scirp.90483-ref9">9</xref>] .</p><p>Clinically, there is pain of the thrombosed limb, swelling, local heat, reduced calf wobble, dorsiflexion of the foot awakens pain (Homans sign) [<xref ref-type="bibr" rid="scirp.90483-ref10">10</xref>] . In our patient all these were present. Thrombosis is confirmed by veno Doppler ultrasound. It finds the incompressibility of the vein or the partial compressibility of the vein by the ultrasound probe [<xref ref-type="bibr" rid="scirp.90483-ref10">10</xref>] . In our case the venous ultrasonography showed the presence of acute deep vein thrombosis of the right lateral vein as illustrated in <xref ref-type="fig" rid="fig1">Figure 1</xref>.</p><p>Other complementary examinations are important notably phlebography which is the reference examination but remains today less and less used in clinical practice by the fact that it is invasive. The D dimer positive if &gt;500 ng/ml and they have a negative predictive value to 90% [<xref ref-type="bibr" rid="scirp.90483-ref10">10</xref>] . In our case the D-dimers were 800 ng/ml.</p><p>Indeed, during tuberculosis several mechanisms can induce a state of blood hypercoagulability causing thromboembolic complications. Tuberculosis, in its different localizations, can induce in the blood an activation of the mononuclear cells whose interaction with Mycobacterium tuberculosis induces an increased synthesis of the interleukin 6 (IL6), the interleukin 1 and the tumor necrotif alfa factor [<xref ref-type="bibr" rid="scirp.90483-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.90483-ref5">5</xref>] . According to White, rifampicin was associated with an increased risk of DVT with a frequency of 4.74% in patients receiving rifampicin [<xref ref-type="bibr" rid="scirp.90483-ref9">9</xref>] ; which corroborates with our clinical case.</p><p>The occurrence of venous thrombosis is classically reported during HIV infection suggesting a pro-thrombotic state of HIV infection. Our case is a perfect illustration. These thrombotic events would be multifactorial due to a state of hypercoagulability caused by HIV itself, notably through a decrease in protein C, a prolonged inflammatory state due to opportunistic infections and the iatrogenic effect of anti-proteases [<xref ref-type="bibr" rid="scirp.90483-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.90483-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.90483-ref8">8</xref>] .</p><p>From the point of view of treatment, the patient has benefited from heparin therapy and an anti vitamin K allowing to have an INR in the therapeutic range</p><p>which is between 2 and 3 in venous thromboembolism. The evolution was favorable under treatment with the disappearance of local signs of DVT.</p></sec><sec id="s4"><title>4. Conclusion</title><p>Tuberculosis and HIV infection are chronic infections that lead to widespread inflammation predisposing patients to MTVE, rifampicin, and anti proteases.</p></sec><sec id="s5"><title>5. Iconography</title><p>Venous Doppler echo of the lower limbs: shows the presence of acute veinous thrombosis of the right lateral vein.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Sylla, D., Kake, A., Camara, A., Barry, I.S., Camara, I., Diane, B.F., Traore, F.A., Beavogui, M. and Balde, M.D. (2019) Deep Vein Thrombosis in HIV and Tuberculosis Treatment in a Case of a 19-Year-Old Guinean Student. Open Journal of Internal Medicine, 9, 1-4. https://doi.org/10.4236/ojim.2019.91001</p></sec></body><back><ref-list><title>References</title><ref id="scirp.90483-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Anderson, F.A., Wheeler, H.B., Goldberg, R.J., Hosmer, D.W. and Forcier, A. (1991) Physician Practices in the Prevention of Venous Thromboembolism. Annals of Internal Medicine, 115, 591-595. https://doi.org/10.7326/0003-4819-591</mixed-citation></ref><ref id="scirp.90483-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Malzi, I., Ardouz, E., Alami, S.M. and Marc, K. (2012) Tuberculose et maladie thromboembolique. Revue des Maladies Respiratoires, 29, A115. https://doi.org/10.1016/j.rmr.2011.10.379</mixed-citation></ref><ref id="scirp.90483-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Tazi-Mezalek, Z., Alaoui-Bennasser, H., Maamar, M., Harmouche, H. and Adnaoui, M. (2004) Thrombose et infection à VIH: à propos de 10 cas. [Thrombosis and HIV Infection: About 10 Cases.]</mixed-citation></ref><ref id="scirp.90483-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Turken, O., Kunter, E., Sezer, M., Solmazgul, E., Cerrahoglu, K., Bozkanat, E., et al. (2002) Hemostatic Changes in Active Pulmonary Tuberculosis. International Journal of Tuberculosis and Lung Disease, 6, 927-932.</mixed-citation></ref><ref id="scirp.90483-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Abdelkarim, S. (2011) Spondylodiscite tuberculeuse compliquée d’une ischémie aigu&amp;euml; des membres inférieurs—à propos d’un cas. Pan African Medical Journal, 8, 45.</mixed-citation></ref><ref id="scirp.90483-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Bibas, M., Biava, G. and Antinori, A. (2011) HIV Associated Venous Thromboembolism. Mediterranean Journal of Hematology and Infectious Diseases, 3, 326-329. https://doi.org/10.4084/mjhid.2011.030</mixed-citation></ref><ref id="scirp.90483-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Crum-Cianflone, N., Weekes, J. and Bavaro, M. (2008) Thromboses among HIV Infected Patients during the HAART Era. AIDS Patient Care STDs, 22, 771-778. https://doi.org/10.1089/apc.2008.0010</mixed-citation></ref><ref id="scirp.90483-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Lifjering, W.M., Ten Kate, M.A., Sprenger, H.G. and Van der Meer, J. (2006) Absolute Risk of Venous and Arterial Thrombosis in HIV-Infected Patients and Effects of Combination Antiretroviral Therapy. Journal of Thrombosis and Haemostasis, 4, 1928-1930. https://doi.org/10.1111/j.1538-7836.2006.02047.x</mixed-citation></ref><ref id="scirp.90483-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">White, N.W. (1989) Venous Thrombosis and Rifampicin. The Lancet, 2, 434-435. https://doi.org/10.1016/S0140-6736(89)90603-X</mixed-citation></ref><ref id="scirp.90483-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Besse, B., Lellouche, N. and Attias, D. (2006) Epreuve nationale classante; cardiologie et maladies vasculaires; maladies veineuse thrombo embolique page 123; ed.</mixed-citation></ref></ref-list></back></article>